Haibing Zhou

26PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical devicesCharacterisation of biological macromoleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 13, 2026
A Novel Dual-Targeting PROTAC Overcomes Endocrine Resistance by Engaging Orthosteric and Allosteric Sites of Estrogen Receptor α.

|Jul 07, 2026
Discovery of Effective Dual PROTAC Degraders with Synergistic Antitumor Activity for Overcoming Tamoxifen-Resistant Breast Cancer.

|May 26, 2026
Hydrophobic Tag Degraders Overcome Endocrine-Resistant Breast Cancer by Recruiting HSP27-Mediated E3 Ligase Complex for ERα Proteasomal Degradation.

|Apr 08, 2026
Identification of Novel Amino Acid-based PROTACs Exhibiting Broad-Spectrum Antiviral Activity Against Enteroviruses.

Tianai Fan, Maoze Yang, Yumeng Cai

|Nov 11, 2025
Kill Two Birds with One Stone: An Efficient and Potent AR CBS-Targeted Degrader Reverses Breast Cancer Resistance via Concurrent AR Degradation and ERα Transcriptional Suppression.

Yihe Wu, Baohua Xie, Jinsen Liang

|Jun 18, 2025
Discovery of ERα-targeting PROTACs with intrinsic fluorescence for precision theranostics of breast cancer.

Yihe Wu, Junhong Dai, Xiaofei Deng

Pageof 5

Frequent Collaborators

6 joint publications

Chune Dong

3 joint publications

Lilan Xin

2 joint publications

Yongshi Yu

2 joint publications

Chang Min